Our Weight Loss Medications
Zynox RX offers clinically supported GLP-1 receptor agonist medications prescribed by licensed telehealth providers.
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally approved for type 2 diabetes that has shown remarkable effectiveness for chronic weight management. It works by mimicking a hormone your body naturally produces to regulate appetite and blood sugar.
- Reduces appetite and calorie intake
- Slows gastric emptying to keep you feeling full longer
- Supports significant, sustained weight loss over time
- Weekly self-injection, easy to use at home
Quick Facts
💉 Weekly injection
⚖️ Proven weight reduction of 15-20% body weight in studies
💚 GLP-1 receptor agonist
🏠 Telehealth prescribed
Quick Facts
💉 Weekly injection
⚖️ Up to 22% body weight reduction in clinical trials
🌟 Dual GIP & GLP-1 agonist
🏠 Telehealth prescribed
Tirzepatide
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist, making it one of the most powerful weight loss medications available today. It targets two key metabolic pathways to deliver superior results for eligible patients.
- Dual-action mechanism for enhanced weight loss
- Significantly reduces hunger and cravings
- Improves insulin sensitivity and blood sugar control
- Once-weekly self-injection
Liraglutide
Liraglutide is a well-established GLP-1 receptor agonist with a long track record in both diabetes management and weight loss. Administered as a daily injection, it provides consistent appetite control throughout the day.
- Daily injection for steady, consistent coverage
- Well-studied safety and efficacy profile
- Reduces appetite and promotes satiety
- Suitable for patients who prefer daily dosing flexibility
Quick Facts
💉 Daily injection
⚖️ Average 5-8% body weight loss in studies
📊 Long-established clinical record
🏠 Telehealth prescribed
Ready to Find the Right Medication for You?
Schedule a $45 telehealth consultation and our licensed providers will determine the best medication plan for your goals.